A randomized, double-blind, placebo-controlled trial of olanzapine versus placebo plus ondansetron and dexamethasone for antiemetic prophylaxis in patients receiving oxaliplatin-, irinotecan-, or carboplatin-based chemotherapy. [PDF]
Harikul W +6 more
europepmc +1 more source
Incidence and clinical characteristics of zolbetuximab-induced nausea and vomiting in CLDN18.2-positive unresectable advanced or recurrent gastric cancer: a retrospective study. [PDF]
Ando Y +16 more
europepmc +1 more source
Perioperative interventions in preventing postoperative delirium following orthopaedic surgery in the elderly: a Bayesian network meta-analysis. [PDF]
Cai X, Shen K, Xiong H, Chen Q, Ma D.
europepmc +1 more source
Safety, Tolerability, and Pharmacokinetics of Subcutaneous Extended-Release Injectable Olanzapine in Patients with Schizophrenia and Schizoaffective Disorder. [PDF]
Cherniakov I +13 more
europepmc +1 more source
Olanzapine Overdose-Induced Bradycardia in a Young Adult With Major Depressive Disorder: A Case Report and Literature Review. [PDF]
Palangi MG +3 more
europepmc +1 more source
Second-Generation Antipsychotics for Depression in Serious Illness: A First-Line Augmentation Strategy. [PDF]
Robbins-Welty G +7 more
europepmc +1 more source
Severe Nondiabetic Hypoglycemia After Risperidone Initiation in an Adult With Schizophrenia: A Case Report and Systematic Review. [PDF]
Sarker A, Yusuf M, Gillespie M.
europepmc +1 more source
Thromboembolic events with olanzapine: a systematic review integrating meta-analysis and FAERS database. [PDF]
Zhang X +8 more
europepmc +1 more source
A meta-analysis of the incidence proportion of obesity and associated risk factors in patients with schizophrenia. [PDF]
Long J, Yang B, Zheng Q.
europepmc +1 more source
Seizures Risk Related to Atypical Antipsychotics: A Disproportionality Analysis Based on the FDA Adverse Event Reporting System (FAERS). [PDF]
Zhao X +5 more
europepmc +1 more source

